Resistance of propionibacteria to antibiotics used in the treatment of acne

References

1. Adams S. J., Cooke E. M., Cunliffe W. J. 1981; The use of oral and topical antibiotics in acne. Journal of Antimicrobial Chemotherapy 7: suppl A75–80
   [Google Scholar]
2. Bernstein J. E., Shalita A. R. 1980; Effects of topical erythromycin on aerobic and anaerobic surface flora. Acta Dermatovener (Stockholm) 60:537–539
   [Google Scholar]
3. Chow A. W., Patten V., Guze L. G. 1975; Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline and tetracycline. Antimicrobial Agents and Chemo-therapy 7:46–49
   [Google Scholar]
4. Cohen L. E., McNeill C. J., Wells R. F. 1973; Clindamycin associated colitis. Journal of the American Medical Association 223:1379–80
   [Google Scholar]
5. Corse J., Williams R. E. O. 1968; Antibiotic resistance of coagulase-negative staphylococci and micrococci. Journal of Clinical Pathology 21:722–728
   [Google Scholar]
6. Cove J. H., Cunliffe W. J., Holland K. T. 1980; Acne vulgaris: is the bacterial population size significant. British Journal of Dermatology 102:277–280
   [Google Scholar]
7. Crawford W. W., Crawford I. P., Stoughton R. B., Cornell R. C. 1979; Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. Journal of Investigative Dermatology 72:187–190
   [Google Scholar]
8. Cummins C. S., Johnson J. L. 1974; Corynebacterium parvum: a synonym for Propionibacterium acnes?. Journal of General Microbiology 80:433–442
   [Google Scholar]
9. Cunliffe W. J., Clayden A. D., Gould D., Simpson N. B. 1981; Acne vulgaris—its aetiology and treatment. A review. Clinical and Experimental Dermatology 6:461–469
   [Google Scholar]
10. Cunliffe W. J., Forster R. A., Greenwood N. D., Hetherington C., Holland K. T., Holmes R. L., Khan S., Roberts C. D., Williams M., Williamson B. 1973; Tetracycline and acne vulgaris: a clinical and laboratory investigation. British Medical Journal 4:332–335
    [Google Scholar]
11. Esterly N. B., Furey N. L., Flanagan L. E. 1978; The effect of antimicrobial agents on leukocyte chemotaxis. Journal of Investigative Dermatology 70:51–55
    [Google Scholar]
12. Feltham R. K. A., Power A. K., Pell P. A., Sneath P. H. A. 1978; A simple method for storage of bacteria at –76 °C. Journal of Applied Bacteriology 44:313–316
    [Google Scholar]
13. Gould D. J., Cunliffe W. J. 1978; The long term treatment of acne vulgaris. Clinical and Experimental Dermatology 3:249–252
    [Google Scholar]
14. Gould D. J., Ingham E., Gowland G., Cunliffe W. J. 1979; Leucocyte chemotaxis in acne vulgaris: the role played by P. acnes and host factors. British Journal of Dermatology 101:104–105
    [Google Scholar]
15. Guin J. D., Huber D. S., Gierlerak P. L. 1979; Antibiotic sensitivity of comedonal Propionibacterium acnes. Acta Dermato Venereologica 59:552–554
    [Google Scholar]
16. Hassing G. S. 1971; Inhibition of Corynebacterium acnes lipase by tetracycline. Journal of Investigative Dermatology 56:189–192
    [Google Scholar]
17. Hoeffler U., Ko H. L., Pulverer G. 1976; Antimicrobial susceptibility of Propionibacterium acnes and related microbial species. Antimicrobial Agents and Chemotherapy 10:387–394
    [Google Scholar]
18. Hoeffler U., Niederau W., Pulverer G. 1980; Susceptibility of cutaneous propionibacteria to newer antibiotics. Chemotherapy 26:7–11
    [Google Scholar]
19. Holdeman L. V., Moore W. E. C. 1972 Anaerobe laboratory manual Virginia Polytechnic Institute and State University; Blacksburg, VA:
    [Google Scholar]
20. Holland K. T., Ingham E., Cunliffe W. J. 1981; The microbiology of acne. Journal of Applied Bacteriology 51:195–215
    [Google Scholar]
21. Lee W. L., Shalita A. R., Suntharalingam K., Fikrig S. M. 1982; Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infection and Immunity 35:71–78
    [Google Scholar]
22. Leyden J. J. 1976; Antibiotic resistant acne. Cutis 17:593–596
    [Google Scholar]
23. Leyden J. J., McGinley K. J., Kligman A. M. 1982; Tetracycline and minocycline treatment. Effects on skin-surface lipid levels and Propionibacterium acnes. Archives of Dermatology 118:19–22
    [Google Scholar]
24. Marples R. R., Kligman A. M. 1971; Ecological effects of oral antibiotics on the microflora of human skin. Archives of Dermatology 103:148–153
    [Google Scholar]
25. Marples R. R., Downing D. T., Kligman A. M. 1971; Control of free fatty acids in human surface lipids by Corynebacterium acnes. Journal of Investigative Dermatology 56:127–131
    [Google Scholar]
26. Martin W. J., Gardner M., Washington J. A. 1972; In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrobial Agents and Chemotherapy 1:148–158
    [Google Scholar]
27. Milstone E. B., McDonald A. J., Scholhamer C. F. 1981; Pseudomembranous colitis after topical application of clindamycin. Archives of Dermatology 117:154–155
    [Google Scholar]
28. Noble W. C. 1981; Choice of topical antibiotic—a microbiological viewpoint. Clinical and Experimental Dermatology 6:503–507
    [Google Scholar]
29. Puhvel S. M., Sakamoto M. 1977; A re-evaluation of fatty acids as inflammatory agents in acne. Journal of Investigative Dermatology 68:93–97
    [Google Scholar]
30. Puhvel S. M., Sakamoto M. 1980; Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis). Journal of Investigative Dermatology 74:36–39
    [Google Scholar]
31. Rashleigh P. L., Rife E., Goltz R. W. 1967; Tetracycline levels in skin surface film after oral administration of tetracycline to normal adults and to patients with acne vulgaris. Journal of Investigative Dermatology 49:611–615
    [Google Scholar]
32. Resh W., Stoughton R. B. 1976; Topically applied antibiotics in acne vulgaris. Clinical response and suppression of Corynebacterium acnes in open comedones. Archives of Dermatology 112:182–184
    [Google Scholar]
33. Smith M. A., Water worth P. M. 1961; The bacteriology of acne vulgaris in relation to its treatment with antibiotics. British Journal of Dermatology 73:152–159
    [Google Scholar]
34. Stoughton R. B. 1979; Topical antibiotics for acne vulgaris. Current usage. Archives of Dermatology 115:486–489
    [Google Scholar]
35. Tally F. P., Jacobus N. V., Bartlett J. G., Gorbach S. L. 1975; Susceptibility of anaerobes to cefoxitin and other cephalosporins. Antimicrobial Agents and Chemotherapy 7:128–132
    [Google Scholar]
36. Unkles S. E., Gemmell C. G. 1982; Effect of clindamycin, erythromycin, lincomycin and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. Antimicrobial Agents and Chemotherapy 21:39–43
    [Google Scholar]
37. Wang W. L. L., Everett E. D., Johnson M., Dean E. 1977; Susceptibility of Propionibacterium acnes to seventeen antibiotics. Antimicrobial Agents and Chemotherapy 11:171–173
    [Google Scholar]
38. Weaber K., Freedman R., Eudy W. W. 1971; Tetracycline inhibition of a lipase from Corynebacterium acnes. Applied Microbiology 21:639–642
    [Google Scholar]
39. Webster G. F., McGinley K. J., Leyden J. J. 1981; Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. British Journal of Dermatology 104:453–457
    [Google Scholar]
40. Weeks J. G., McCarty L., Black T., Fulton J. E. 1977; The inability of a bacterial lipase inhibitor to control acne vulgaris. Journal of Investigative Dermatology 69:236–243
    [Google Scholar]
41. Williamson P., Kligman A. M. 1965; A new method for the quantitative investigation of cutaneous bacteria. Journal of Investigative Dermatology 45:498–503
    [Google Scholar]